3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
90
Phase 1
37
Phase 1/2
24
Phase 3
7
Phase EARLY_PHASE1
3
Phase 2/3
3
Phase 4
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
3
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Waldenstrom Macroglobulinemia
1
Multiple Myeloma
1
Interventions
Dexamethasone
49
Metformin
47
Cyclophosphamide
42
Saline Solution
38
Cytarabine
34
Sodium Chloride
32
Bupivacaine
31
Vincristine
27
Cisplatin
26
Propofol
25
Methotrexate
25
Letrozole
24
Fluorouracil
24
Dexmedetomidine
24
Doxorubicin
23
Fentanyl
22
Carboplatin
22
Etoposide
19
Rituximab
18
Morphine
18
Bevacizumab
18
Acetaminophen
18
Lidocaine
17
Granulocyte Colony-Stimulating Factor
17
Prednisone
16
Mercaptopurine
16
Docetaxel
16
Clomiphene
16
Sevoflurane
15
Ropivacaine
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
OTHER
×
ibrutinib
×
Clear all
NCT07474961
2026-03-16
BLOOD-dose
Rigshospitalet, Denmark
Phase 4
Not yet recruiting
400 enrolled